Literature DB >> 21441402

Immune complexes in acute adult-onset Henoch-Schonlein nephritis.

Marc Hilhorst1, Pieter van Paassen, Peter van Breda Vriesman, Jan Willem Cohen Tervaert.   

Abstract

BACKGROUND: Adult-onset Henoch-Schönlein purpura nephritis (HSPN) and primary IgA (IgAN) nephropathy have been considered indistinguishable immunohistopathologically and are often considered as two extremes of one disease entity. We postulate that adult-onset Henoch-Schönlein can be distinguished histologically from primary IgAN and that both diseases differ in their immunopathological mechanisms.
METHODS: Twenty consecutive patients with adult-onset HSPN were studied. Serum was analysed for circulating IgA immune complexes; renal biopsies were analysed by light and electron microscopy (EM). As disease controls, 40 IgAN patients were studied.
RESULTS: Intracapillary leukocyte margination was seen in 15 of the 20 patients and cellular crescent formation in all renal biopsies of the HSPN patients. IgAN biopsies showed a few small crescents without intracapillary leukocytes. In 16 HSPN patients, EM was performed and in 10, no dense deposits were found. In all biopsies of IgAN patients, typical 'humps' were found. In 6 of 9 analysed HSPN patients, intermediate to large circulating immune complexes were found, whereas in 4 of 28 analysed patients with primary IgAN small circulating immune complexes were found.
CONCLUSIONS: We consider adult-onset HSPN distinguishable in histology and ultrastructure from primary IgAN. We believe adult-onset Henoch-Schönlein to be a circulating immune complex disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441402     DOI: 10.1093/ndt/gfr149

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  IgA vasculitis (formerly Henoch-Schönlein purpura) in an adult with systemic lupus erythematosus.

Authors:  Vera Bernardino; Pedro Mendes-Bastos; Ana Rodrigues; Nuno Riso
Journal:  BMJ Case Rep       Date:  2015-09-09

Review 3.  IgA vasculitis with nephritis: update of pathogenesis with clinical implications.

Authors:  M Colleen Hastings; Dana V Rizk; Krzysztof Kiryluk; Raoul Nelson; Rima S Zahr; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2021-04-05       Impact factor: 3.651

4.  Beneficial Effects of Qingzixiaoban Granule on Henoch-Schönlein Purpura Nephritis Mice through Inhibiting Immune Complex Deposition and Th2 Immunodeviation.

Authors:  Hui Yang; Jing Guan; Pei Ma; Yannan Fan; Jinye Bai; Shuyi Li; Jiqiao Yuan; Yecheng Jin; Mingbao Lin; Jianmin Zhang; Qi Hou
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-16       Impact factor: 2.629

5.  A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.

Authors:  Motonori Sugiyama; Yukihiro Wada; Nobuhiro Kanazawa; Shohei Tachibana; Taihei Suzuki; Kei Matsumoto; Masayuki Iyoda; Hirokazu Honda; Takanori Shibata
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

6.  Adult-Onset Immunoglobulin A Vasculitis With Renal Involvement.

Authors:  Si Yuan Khor; Abdul-Fatawu Osman; Issa Haddad; Sara AlAttal; Nazia Khan
Journal:  Cureus       Date:  2022-03-30

Review 7.  IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers.

Authors:  Liyun Xu; Yongzhen Li; Xiaochuan Wu
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

8.  Renal Prognosis and Related Risk Factors for Henoch-Schönlein Purpura Nephritis: A Chinese Adult Patient Cohort.

Authors:  Xiao Huang; Xiaomei Wu; Weibo Le; Yaxin Hao; Jing Wu; Caihong Zeng; Zhihong Liu; Zheng Tang
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.